Tops & Flops Stocks
Security | Change (%) ▲ | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
X4 Pharmaceuticals, Inc. | -6.110% | 5.932% | 44.509% | 62.338% | 60.256% | - | - |
Optibiotix Health plc | -5.980% | -13.971% | -16.429% | 108.929% | -20.408% | -58.947% | - |
Chromadex Corp | -5.950% | 15.714% | 105.063% | 129.787% | 141.791% | -57.647% | - |
Qualigen Therapeutics Inc. | -5.680% | 7.353% | -15.607% | -55.488% | -27.146% | -98.453% | - |
Sihuan Pharmaceutical Holdings Group Ltd. | -5.650% | -0.800% | -1.587% | -37.374% | -9.489% | -71.818% | -69.000% |
Puma Biotechnology Inc. | -5.620% | 14.535% | -19.130% | 117.631% | 26.120% | -41.460% | - |
Bluebird Bio Inc. | -5.550% | -11.115% | -22.905% | -69.942% | -4.412% | -95.357% | - |
BioLase Inc. | -5.520% | - | - | - | - | - | - |
Hexo Corp. | -5.340% | - | - | - | - | - | - |
Erytech Pharma S.A. | -5.170% | - | - | - | - | - | - |
Prescient Therapeutics Ltd. | -5.170% | - | - | - | - | - | - |
Fibrogen Inc. | -5.000% | -2.679% | 18.478% | -87.096% | 153.488% | -91.950% | - |
Smith & Nephew plc | -4.980% | -3.849% | -5.016% | -8.638% | -6.005% | -26.625% | - |
Paion AG | -4.910% | - | - | - | - | - | - |
Oncopeptides AB | -4.840% | 17.572% | 14.833% | -53.840% | -36.209% | - | - |
Newegg Commerce Inc. | -4.760% | -22.222% | -8.197% | -30.000% | -31.148% | -87.931% | -91.250% |
Astellas Pharma Inc. | -4.750% | -3.167% | -2.411% | -25.024% | -7.810% | -26.078% | -24.258% |
Oncolytics Biotech | -4.730% | - | - | - | - | - | - |
Organigram Holdings Inc. | -4.720% | -12.069% | 7.368% | -12.431% | 58.140% | -82.759% | -91.341% |
Maternus-Kliniken AG | -4.710% | 0.532% | -18.534% | 1.070% | -28.409% | -54.348% | -4.061% |
Cumberland Pharmaceuticals | -4.690% | - | - | - | - | - | - |
Sensorion SA | -4.630% | -5.527% | -10.909% | 137.480% | 83.750% | -67.621% | - |
CSPC Pharmaceutical Group Ltd | -4.620% | -3.853% | 0.970% | -17.672% | -10.994% | -27.358% | -14.171% |
Pharmaxis Ltd. | -4.550% | - | - | - | - | - | - |
Trinity Biotech ADR | -4.440% | - | - | - | - | - | - |